Literature DB >> 22177236

10 years of MS instrumental developments--impact on LC-MS/MS in clinical chemistry.

Markus Himmelsbach1.   

Abstract

The combination of liquid chromatography and mass spectrometry (LC-MS) is a powerful and indispensable analytical tool that is widely applied in many areas of chemistry, medicine, pharmaceutics and biochemistry. In this review recent MS instrumental developments are presented as part of a special issue covering various aspects of liquid chromatography tandem mass spectrometry (LC-MS/MS) in clinical chemistry. Improvements, new inventions as well as new combinations in ion source technology are described focusing on dual or multimode sources and atmospheric pressure photoionization (APPI). Increasing demands regarding sensitivity, accuracy, resolution and both quantitation and identification guarantee on-going improvements in mass analyzer technology. This paper discusses new hybrid MS instruments that can perform novel scan modes as well as high-resolution mass spectrometers (HRMS) that finally seem to be able to overcome, or at least significantly reduce, their weaknesses in quantitative applications. Ion mobility-mass spectrometry (IMMS) itself is not an invention of the last 10 years, but a lot of progress was made within the last decade that reveals the potential benefits of this combination. This is clearly reflected by the increased number of commercially available instruments and the various designs of IMMS are covered in detail in this review. Selected applications for all these instrumental developments are given focusing on the perspective of clinical chemistry.
Copyright © 2011 Elsevier B.V. All rights reserved.

Mesh:

Year:  2011        PMID: 22177236     DOI: 10.1016/j.jchromb.2011.11.038

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

Review 1.  Clinical metabolomics: the next stage of clinical biochemistry.

Authors:  Angelo D'Alessandro; Bruno Giardina; Federica Gevi; Anna Maria Timperio; Lello Zolla
Journal:  Blood Transfus       Date:  2012-05       Impact factor: 3.443

2.  A Functional Group Approach for Prediction of APPI Response of Organic Synthetic Targets.

Authors:  Konstantin O Zhurov; Laure Menin; Thomas Di Franco; Yury O Tsybin
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-21       Impact factor: 3.109

Review 3.  Clinical Chemistry Laboratory Automation in the 21st Century - Amat Victoria curam (Victory loves careful preparation).

Authors:  David A Armbruster; David R Overcash; Jaime Reyes
Journal:  Clin Biochem Rev       Date:  2014-08

Review 4.  Usage and limitations of liquid chromatography-tandem mass spectrometry (LC-MS/MS) in clinical routine laboratories.

Authors:  Christoph Seger
Journal:  Wien Med Wochenschr       Date:  2012-11-06

5.  Quantitative UPLC-MS/MS assay of urinary 2,8-dihydroxyadenine for diagnosis and management of adenine phosphoribosyltransferase deficiency.

Authors:  Margret Thorsteinsdottir; Unnur A Thorsteinsdottir; Finnur F Eiriksson; Hrafnhildur L Runolfsdottir; Inger M Sch Agustsdottir; Steinunn Oddsdottir; Baldur B Sigurdsson; Hordur K Hardarson; Nilesh R Kamble; Snorri Th Sigurdsson; Vidar O Edvardsson; Runolfur Palsson
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-09-14       Impact factor: 3.205

6.  Introduction to Mass Spectrometry for Bimolecular Analysis in a Clinical Laboratory.

Authors:  Y Victoria Zhang; Uttam Garg
Journal:  Methods Mol Biol       Date:  2022

Review 7.  A rough guide to metabolite identification using high resolution liquid chromatography mass spectrometry in metabolomic profiling in metazoans.

Authors:  David G Watson
Journal:  Comput Struct Biotechnol J       Date:  2013-02-15       Impact factor: 7.271

8.  Analysis of Spatiotemporal Urine Protein Dynamics to Identify New Biomarkers for Sepsis-Induced Acute Kidney Injury.

Authors:  Yiming Li; Junke Long; Jiaquan Chen; Jing Zhang; Yi Qin; Yanjun Zhong; Fen Liu; Zhiyong Peng
Journal:  Front Physiol       Date:  2020-03-03       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.